These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8621893)

  • 21. Treatment of rat hemiparkinson model with xenogeneic neural transplantation: tolerance induction by anti-T-cell antibodies.
    Okura Y; Tanaka R; Ono K; Yoshida S; Tanuma N; Matsumoto Y
    J Neurosci Res; 1997 Jun; 48(5):385-96. PubMed ID: 9185663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha beta TCR+ T cells play a nonredundant role in the rejection of heart allografts in mice.
    Exner BG; Que X; Mueller YM; Domenick MA; Neipp M; Ildstad ST
    Surgery; 1999 Aug; 126(2):121-6. PubMed ID: 10455873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adoptive transfer of unresponsiveness to allogeneic skin grafts with hepatic gamma delta + T cells.
    Gorczynski RM
    Immunology; 1994 Jan; 81(1):27-35. PubMed ID: 8132216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8+ T-cell removal reduces survival of minor antigen mismatched islet allografts (CBA-->C3H) in mice treated with anti-CD4 monoclonal antibody.
    Koulmanda M; Mandel TE
    Transplant Proc; 1992 Oct; 24(5):2297-8. PubMed ID: 1413065
    [No Abstract]   [Full Text] [Related]  

  • 25. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
    Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells.
    Margenthaler JA; Kataoka M; Flye MW
    Transplantation; 2003 Jun; 75(12):2119-27. PubMed ID: 12829922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+ T cells.
    Graca L; Le Moine A; Lin CY; Fairchild PJ; Cobbold SP; Waldmann H
    Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10122-6. PubMed ID: 15218097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose.
    Bemelman F; Honey K; Adams E; Cobbold S; Waldmann H
    J Immunol; 1998 Mar; 160(6):2645-8. PubMed ID: 9510162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific unresponsiveness to a retrovirally-transferred class I antigen is controlled through the helper pathway.
    Fraser CC; Sykes M; Lee RS; Sachs DH; LeGuern C
    J Immunol; 1995 Feb; 154(4):1587-95. PubMed ID: 7836744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allo-I-J determinants participate in maintenance of neonatal H-2 tolerance.
    Mohler KM; Strome PG; Streilein JW
    J Immunol; 1987 Jan; 138(1):70-7. PubMed ID: 2946781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts.
    Sentman CL; Kumar V; Koo G; Bennett M
    J Immunol; 1989 Mar; 142(6):1847-53. PubMed ID: 2646375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression.
    Honey K; Cobbold SP; Waldmann H
    J Immunol; 1999 Nov; 163(9):4805-10. PubMed ID: 10528180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of CD4+ and CD8+ T cells in proislet allograft and xenograft rejection.
    Simeonovic CJ; Wilson JD
    Transplant Proc; 1992 Feb; 24(1):252-3. PubMed ID: 1539270
    [No Abstract]   [Full Text] [Related]  

  • 36. Strain variation in susceptibility to monoclonal antibody-induced transplantation tolerance.
    Davies JD; Cobbold SP; Waldmann H
    Transplantation; 1997 Jun; 63(11):1570-3. PubMed ID: 9197347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
    Young KJ; DuTemple B; Phillips MJ; Zhang L
    J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of FK 506 on CD4+ and CD8+ T-cell function in vivo.
    Fukuzawa M; Okada A; Shearer GM
    Transplant Proc; 1991 Dec; 23(6):2945-7. PubMed ID: 1721321
    [No Abstract]   [Full Text] [Related]  

  • 39. H-41, a new minor histocompatibility locus. I. Histogenetic analysis.
    Juretić A; Vucak I; Malenica B; Nagy ZA; Klein J
    J Immunol; 1984 Dec; 133(6):2950-4. PubMed ID: 6386980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The T cell populations mediating rejection of MHC class I disparate skin grafts in mice.
    Rosenberg AS
    Transpl Immunol; 1993; 1(2):93-9. PubMed ID: 7915953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.